SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: steve kammerer who wrote (10310)2/18/2011 9:46:12 PM
From: tom pope  Read Replies (1) of 10345
 
Don't know the answer to your question, but I doubt this will help much. (Stolen from Dew's IHub board.

95 PML cases, 20 deaths reported since 2007 relaunch

* Estimated incidence of PML per 1,000 patients now 1.16

NEW YORK Feb 18 (Reuters) - Ten more patients taking Biogen Idec's (BIIB.O) multiple sclerosis drug Tysabri developed the serious brain infection known as PML last month and there were reports of four more deaths, according to a monthly update by the U.S. biotechnology company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News